Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Innovation Pharmaceuticals Inc. | ipix_8k.htm |
EXHIBIT 16.1
[Baker Tilly Letterhead]
December 18, 2018
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
We have read the statements under item 4.01 in the Form 8-K dated December 18, 2018, of Innovation Pharmaceuticals Inc. to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm.
Sincerely,
/s/ Baker Tilly Virchow Krause, LLP
Minneapolis, Minnesota